How PK Modeling Can Inform Sample Size Estimation and Dose Selection for Your Product
Camargo
FEBRUARY 10, 2021
Pharmacokinetics (PK) and bioequivalence (BE) studies serve as the foundation of determining the fate of drug products. This blog post will discuss how PK modeling can contribute to sample size estimation, a key aspect of a clinical trial protocol.
Let's personalize your content